Assessing the effect of baseline status of serum bone turnover markers and vitamin D levels on efficacy of teriparatide 20 μg/day administered subcutaneously in Japanese patients with osteoporosis

Effects of teriparatide in Japanese and non-Japanese populations: bridging findings on pharmacokinetics and efficacy

(2011) Mika Tsujimoto et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Consistency of fracture risk reduction in Japanese and Caucasian osteoporosis patients treated with teriparatide: a meta-analysis

(2011) Toshitaka Nakamura et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-Month, randomized, placebo-controlled, double-blind and 12-month open-label phases

(2010) Akimitsu Miyauchi et al.   BONE

Dual X-ray absorptiometry quality control: Comparison of visual examination and process-control charts

(2010) Ying Lu et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards

(2010) S. Vasikaran et al.   OSTEOPOROSIS INTERNATIONAL

Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study

(2008) Akimitsu Miyauchi et al.   JOURNAL OF BONE AND MINERAL METABOLISM